Cancer Immunology Research


Publication Venue For

  • Circulating Tregs Accumulate in Omental Tumors and Acquire Adipose-Resident Features.  10:641-655. 2022
  • Early-life microbiota exposure restricts myeloid-derived suppressor cell–driven colonic tumorigenesis.  7:544-551. 2019
  • Blockade of CTLA-4 and PD-1 enhances adoptive t-cell therapy efficacy in an ICOS-mediated manner.  7:1803-1812. 2019
  • Lessons learned from checkpoint blockade targeting PD-1 in multiple myeloma.  7:1224-1229. 2019
  • TAM family receptor kinase inhibition reverses MDSC-mediated suppression and augments anti–PD-1 therapy in melanoma.  7:1672-1686. 2019
  • Intravesical BCG Induces CD4+ T-cell expansion in an immune competent model of bladder cancer.  5:594-603. 2017
  • A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice.  5:468-479. 2017
  • The intratumoral balance between metabolic and immunologic gene expression is associated with anti-PD-1 response in patients with renal cell carcinoma.  4:726-733. 2016
  • Expression of the MHC class II pathway in triple-negative breast cancer tumor cells is associated with a good prognosis and infiltrating lymphocytes.  4:390-399. 2016
  • SOCS3 deficiency in myeloid cells promotes tumor development: Involvement of STAT3 activation and myeloid-derived suppressor cells.  3:727-740. 2015
  • T-cell expression of IL10 is essential for tumor immune surveillance in the small intestine.  3:806-814. 2015
  • Ipilimumab-induced encephalopathy with a reversible splenial lesion.  3:598-601. 2015
  • International Standard Serial Number (issn)

  • 2326-6066
  • Electronic International Standard Serial Number (eissn)

  • 2326-6074